Health Highlights: April 12, 2022

New Drug Halves Death Rate in Those With Severe COVID, Maker Claims: An experimental medication for critically ill COVID patients has worked so well that the drug's maker announced Monday it has stopped its clinical trial early and will apply for emergency use authorization. Read more
Philadelphia Becomes First US City to Bring Back Mask Mandate: Faced with rising COVID-19 case counts, the city announced Monday that it will reinstate an indoor mask mandate next week. Read more
Study Finds Just One Dose of HPV Vaccine May be Enough: A single shot provided as much protection against cervical cancer as the standard three-dose regimen, a finding that researchers say could be a game-changer in efforts to vaccinate more people against the human papillomavirus. Read more
Could Some Rheumatoid Arthritis Meds Help Lower Alzheimer's Risk? Preliminary findings suggest a class of rheumatoid arthritis drugs known as TNF inhibitors may lower dementia risk in rheumatoid arthritis patients who also suffer from heart disease. Read more
Related Posts
Screening for A-Fib Using Wearable Devices May Be Cost-Effective
FRIDAY, Aug. 5, 2022 (HealthDay News) -- Screening for atrial fibrillation (AF)...
Biden Plans to Send 400 Million N95 Masks to Americans for Free
WEDNESDAY, Jan. 19, 2022 (HealthDay News) -- The Biden administration plans to...
Early Mobilization Not Beneficial for ICU Patients
THURSDAY, Oct. 27, 2022 (HealthDay News) -- For adults undergoing mechanical...
Wegovy y Saxenda ayudan a las personas a perder el peso que recuperaron tras una cirugía para la obesidad
LUNES, 5 de junio de 2023 (HealthDay News) -- Cuando las personas recuperaban...
